Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Sep;72(3):607–614. doi: 10.1038/bjc.1995.381

Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin.

R Chignola 1, R Foroni 1, A Franceschi 1, M Pasti 1, C Candiani 1, C Anselmi 1, G Fracasso 1, G Tridente 1, M Colombatti 1
PMCID: PMC2033892  PMID: 7669569

Abstract

The cytoreductive effects of anti-transferrin receptor (anti-TfnR) immunotoxins (ITs) and of ricin toxin against tumour micromasses have been evaluated in a multicellular tumour spheroid (MTS) model. More than 600 (656) MTSs obtained with human breast carcinoma (MCF7) or rat glioblastoma (9L) cell lines were treated individually with ITs or toxin and the effects induced by the treatment were measured for each MTS as volume variation vs time by applying the Gompertz growth model. Two dose-dependent patterns of MTS growth were observed in MTSs of both cell lines in response to IT or toxin treatment: (1) complete inhibition of MTS growth ('sterilisation'); and (2) partial/complete inhibition ('heterogeneous response'). Within the range of IT or toxin concentrations resulting in partial inhibition of MTS growth, the sensitivity of treated MTSs was extremely heterogeneous (the cytoreductive effects varying between 0.1 and 4 logs of cells killed for a given IT or toxin concentration). Analysis of the post-treatment regrowth kinetics indicated that treated non-sterilised and control MTSs reached the same final limiting volumes. However, the doubling time estimated for the surviving cells of treated MCF7 and 9L MTSs ranged between 15 and 50 h, indicating that each MTS had individual growing potential. In conclusion, our results indicate that at substerilising IT concentrations individual heterogenicity of MTSs may greatly influence the cytoreductive potential of ITs. An implication of our study is that the efficacy of an IT treatment in eradicating disseminated micrometastases may not be predictable a priori. The MTS model that we describe in this paper may help in dissecting out factors limiting the effect of ITs in three-dimensional tumours.

Full text

PDF
607

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brunton G. F., Wheldon T. E. The Gompertz equation and the construction of tumour growth curves. Cell Tissue Kinet. 1980 Jul;13(4):455–460. doi: 10.1111/j.1365-2184.1980.tb00486.x. [DOI] [PubMed] [Google Scholar]
  2. Candiani C., Franceschi A., Chignola R., Pasti M., Anselmi C., Benoni G., Tridente G., Colombatti M. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates. Cancer Res. 1992 Feb 1;52(3):623–630. [PubMed] [Google Scholar]
  3. Cheng F. M., Hansen E. B., Taylor C. R., Epstein A. L. Diffusion and binding of monoclonal antibody TNT-1 in multicellular tumor spheroids. J Natl Cancer Inst. 1991 Feb 6;83(3):200–204. doi: 10.1093/jnci/83.3.200. [DOI] [PubMed] [Google Scholar]
  4. Chignola R., Anselmi C., Franceschi A., Pasti M., Candiani C., Tridente G., Colombatti M. Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events. J Immunol. 1994 Mar 1;152(5):2333–2343. [PubMed] [Google Scholar]
  5. Chignola R., Foroni R., Candiani C., Franceschi A., Pasti M., Stevanoni G., Anselmi C., Tridente G., Colombatti M. Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model. Int J Cancer. 1994 Apr 15;57(2):268–274. doi: 10.1002/ijc.2910570223. [DOI] [PubMed] [Google Scholar]
  6. Demicheli R., Foroni R., Giuliani F. C., Savi G. Influence of tumor growth kinetics on response to doxorubicin treatment of C3H mammary carcinoma. Tumori. 1988 Jun 30;74(3):269–274. doi: 10.1177/030089168807400305. [DOI] [PubMed] [Google Scholar]
  7. Demicheli R., Foroni R., Ingrosso A., Pratesi G., Soranzo C., Tortoreto M. An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data. Cancer Res. 1989 Dec 1;49(23):6543–6546. [PubMed] [Google Scholar]
  8. Demicheli R. Growth of testicular neoplasm lung metastases: tumor-specific relation between two Gompertzian parameters. Eur J Cancer. 1980 Dec;16(12):1603–1608. doi: 10.1016/0014-2964(80)90034-1. [DOI] [PubMed] [Google Scholar]
  9. Demicheli R., Pratesi G., Foroni R. The exponential-Gompertzian tumor growth model: data from six tumor cell lines in vitro and in vivo. Estimate of the transition point from exponential to Gompertzian growth and potential clinical implications. Tumori. 1991 Jun 30;77(3):189–195. doi: 10.1177/030089169107700302. [DOI] [PubMed] [Google Scholar]
  10. Johnson V. G., Wrobel C., Wilson D., Zovickian J., Greenfield L., Oldfield E. H., Youle R. Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia. J Neurosurg. 1989 Feb;70(2):240–248. doi: 10.3171/jns.1989.70.2.0240. [DOI] [PubMed] [Google Scholar]
  11. Kikuchi T., Ohnuma T., Holland J. F., Spitler L. E. Penetration of anti-melanoma immunotoxin into multicellular tumor spheroids and cell kill effects. Cancer Immunol Immunother. 1992;35(5):302–306. doi: 10.1007/BF01741142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kwok C. S., Cole S. E., Liao S. K. Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids. Cancer Res. 1988 Apr 1;48(7):1856–1863. [PubMed] [Google Scholar]
  13. Landaw E. M., DiStefano J. J., 3rd Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. Am J Physiol. 1984 May;246(5 Pt 2):R665–R677. doi: 10.1152/ajpregu.1984.246.5.R665. [DOI] [PubMed] [Google Scholar]
  14. Lloyd H. H. Estimation of tumor cell kill from Gompertz growth curves. Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):267–277. [PubMed] [Google Scholar]
  15. Nicolson G. L., Blaustein J. The interaction of Ricinus communis agglutinin with normal and tumor cell surfaces. Biochim Biophys Acta. 1972 May 9;266(2):543–547. doi: 10.1016/0005-2736(72)90109-5. [DOI] [PubMed] [Google Scholar]
  16. Norton L. Implications of kinetic heterogeneity in clinical oncology. Semin Oncol. 1985 Sep;12(3):231–249. [PubMed] [Google Scholar]
  17. Olsnes S., Pihl A. Chimeric toxins. Pharmacol Ther. 1981;15(3):355–381. doi: 10.1016/0163-7258(81)90050-4. [DOI] [PubMed] [Google Scholar]
  18. Rofstad E. K., Sutherland R. M. Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours. Br J Cancer. 1989 Jan;59(1):28–35. doi: 10.1038/bjc.1989.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. SKIPPER H. E., SCHABEL F. M., Jr, WILCOX W. S. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. Cancer Chemother Rep. 1964 Feb;35:1–111. [PubMed] [Google Scholar]
  20. Sutherland R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 1988 Apr 8;240(4849):177–184. doi: 10.1126/science.2451290. [DOI] [PubMed] [Google Scholar]
  21. Twentyman P. R. Response to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival. Br J Cancer. 1980 Aug;42(2):297–304. doi: 10.1038/bjc.1980.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vitetta E. S., Thorpe P. E., Uhr J. W. Immunotoxins: magic bullets or misguided missiles? Immunol Today. 1993 Jun;14(6):252–259. doi: 10.1016/0167-5699(93)90041-I. [DOI] [PubMed] [Google Scholar]
  23. Walker K. A., Murray T., Hilditch T. E., Wheldon T. E., Gregor A., Hann I. M. A tumour spheroid model for antibody-targeted therapy of micrometastases. Br J Cancer. 1988 Jul;58(1):13–16. doi: 10.1038/bjc.1988.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weinstein J. N., van Osdol W. Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the "binding site barrier". Cancer Res. 1992 May 1;52(9 Suppl):2747s–2751s. [PubMed] [Google Scholar]
  25. Yuhas J. M., Li A. P., Martinez A. O., Ladman A. J. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 1977 Oct;37(10):3639–3643. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES